The Group emphasised its strategy of enhancing sustainability and farmer productivity through a balanced portfolio of crop protection, seeds, and biological solutions

Syngenta Group has announced its financial results for the first half and second quarter of 2025, highlighting a solid recovery in profitability and continued momentum in innovation and biologicals.

Group sales for the first half of 2025 reached $14.5 billion, in line with the prior year and up 2 per cent at constant exchange rates (CER). EBITDA grew 24 per cent year-on-year (+29 per cent at CER) to $2.5 billion, lifting the Group’s EBITDA margin to 17.5 per cent, compared to 14.1 per cent in H1 2024.

Second-quarter sales stood at $7.2 billion, flat year-on-year (+1 per cent CER), while EBITDA rose 32 per cent (+34 per cent CER) to $1.1 billion. Management credited disciplined cost control, R&D investments, and operational efficiency for the improved performance, alongside the flexibility of Syngenta’s global production network.

Business Performance

Crop Protection: Sales rose 3 per cent to $6.4 billion (+7 per cent CER) in the first half, supported by strong growth in Europe (+5 per cent), Asia, the Middle East & Africa (+9 per cent), and China (+9 per cent). North America recorded 10 per cent higher sales, while Latin America and Brazil saw declines of 14 per cent and 5 per cent, respectively.

Product Approvals: Over 800 product approvals were secured in H1, including the launch of ALTESSIA herbicide in India, registrations for TYMIRIUM technology in Brazil and India, and SIMODIS with PLINAZOLIN technology in Thailand.

Biologicals: Sales continued to grow steadily, supported by demand for biocontrols, biostimulants, and nutrient efficiency products. The integration of Novartis’ Strains and Natural Products Collection and the opening of a 22,000 m² biologicals facility in South Carolina marked key milestones to accelerate innovation in this segment.

The Group emphasised its strategy of enhancing sustainability and farmer productivity through a balanced portfolio of crop protection, seeds, and biological solutions.